Comparing different flow rates (20 and 35 l/min) under high-nasal flow therapy for the obstructive sleep apnoea syndrome (OSAS)

G. Nilius, U. Domanskie, K. J. Franke, K. H. Ruhle, H. Schneider (Hagen, Germany; Baltimore, United States Of America)

Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea
Session: Physiology and diagnostic technology in obstructive sleep apnoea
Session type: Thematic Poster Session
Number: 2207
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Nilius, U. Domanskie, K. J. Franke, K. H. Ruhle, H. Schneider (Hagen, Germany; Baltimore, United States Of America). Comparing different flow rates (20 and 35 l/min) under high-nasal flow therapy for the obstructive sleep apnoea syndrome (OSAS). Eur Respir J 2011; 38: Suppl. 55, 2207

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS)
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Effects of continuous positive airways pressure (CPAP) on portal flow in patients with obstructive apnoea syndrome (OSAS)
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007

Effects of treatments with nCPAP on cerebral blood flow velocity in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009


Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Importance of controlled blood pressure values in a population with obstructive sleep apnea syndrome (OSA) and arterial hypertension (HT)
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011


Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Recent weight history in patients with obstructive sleep apnea syndrome (OSAS) prior to continuous positive airway pressure (CPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 648s
Year: 2006

Long-term effects of noninvasive mechanical ventilation (NMV) in COPD patients with obstructive sleep apnoea (OSA) (overlap syndrome)
Source: Eur Respir J 2001; 18: Suppl. 33, 402s
Year: 2001

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 95s
Year: 2003

The effect of volume targeted pressure support (PS) ventilation with autotitrating expiratory positive airways pressure (EPAP) and back up rate (BUR) on sleep quality in COPD-obstructive sleep apnoea (OSA) overlap syndrome
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013

Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Reliability of automatic (Auto-CPAP) pressure titration in patients with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 417s
Year: 2001

Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Source: Sleep and Breathing Conference 2021
Year: 2021

Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 725s
Year: 2005

Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Efficacy of auto servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-Stokes respiration (CSR). A randomized CPAP-controlled trial
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010